Acute antidepressant treatment differently modulates ERK/MAPK activation in neurons and astrocytes of the adult mouse prefrontal cortex

Neuroscience

Volumn 232, Issue , 2013, Pages 161-168

  Di Benedetto, B ^a,b   Radecke, J ^a   Schmidt, M V ^a   Rupprecht, R ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Antidepressants; Astrocyte; ERK; Mouse; Neuron; Prefrontal cortex

Indexed keywords

DESIPRAMINE; FLUOXETINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; ANTIDEPRESSANT AGENT;

ACUTE DRUG ADMINISTRATION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CONFOCAL MICROSCOPY; DRUG EFFECTS; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; NERVE CELL;

ANIMALS; ANTIDEPRESSIVE AGENTS; ASTROCYTES; BLOTTING, WESTERN; CORPUS STRIATUM; DESIPRAMINE; FLUORESCENT ANTIBODY TECHNIQUE; FLUOXETINE; HIPPOCAMPUS; MALE; MICE; MICROSCOPY, CONFOCAL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; PREFRONTAL CORTEX;

EID: 84891771863     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.11.061     Document Type: Article

References (47)

1. Allen N.J., Barres B.A. Neuroscience: Glia - more than just brain glue. Nature 2009, 457:675-677.
2. Araque A., Sanzgiri R.P., Parpura V., Haydon P.G. Astrocyte-induced modulation of synaptic transmission. Can J Physiol Pharmacol 1999, 77:699-706.
3. Araya-Callís C., Hiemke C., Abumaria N., Flugge G. Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus. Psychopharmacology (Berl) 2012, 224:209-222.
4. Atkins C.M., Selcher J.C., Petraitis J.J., Trzaskos J.M., Sweatt J.D. The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1998, 1:602-609.
5. Avruch J. MAP kinase pathways: the first twenty years. Biochim Biophys Acta 2007, 1773:1150-1160.
6. Bessa J.M., Ferreira D., Melo I., Marques F., Cerqueira J.J., Palha J.A., Almeida O.F., Sousa N. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009, 14:764-773, 739.
7. Day J.J., Sweatt J.D. Epigenetic treatments for cognitive impairments. Neuropsychopharmacology 2012, 37:247-260.
8. Di Benedetto B., Kallnik M., Weisenhorn D.M., Falls W.A., Wurst W., Holter S.M. Activation of ERK/MAPK in the lateral amygdala of the mouse is required for acquisition of a fear-potentiated startle response. Neuropsychopharmacology 2009, 34:356-366.
9. Di Benedetto B., Kuhn R., Nothdurfter C., Rein T., Wurst W., Rupprecht R. N-Desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: a putative cellular mechanism for quetiapine as antidepressant. Neuropharmacology 2012, 62:209-216.
10. Duric V., Banasr M., Licznerski P., Schmidt H.D., Stockmeier C.A., Simen A.A., Newton S.S., Duman R.S. A negative regulator of MAP kinase causes depressive behavior. Nat Med 2010, 16:1328-1332.
11. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., Pandey G.N. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 2001, 77:916-928.
12. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 2003, 23:7311-7316.
13. Fumagalli F., Molteni R., Calabrese F., Frasca A., Racagni G., Riva M.A. Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. J Neurochem 2005, 93:1551-1560.
14. Ge W.P., Duan S. Persistent enhancement of neuron-glia signaling mediated by increased extracellular K+ accompanying long-term synaptic potentiation. J Neurophysiol 2007, 97:2564-2569.
15. Gerrits M., Westenbroek C., Koch T., Grootkarzijn A., ter Horst G.J. Increased limbic phosphorylated extracellular-regulated kinase 1 and 2 expression after chronic stress is reduced by cyclic 17beta-estradiol administration. Neuroscience 2006, 142:1293-1302.
16. Guan J.S., Haggarty S.J., Giacometti E., Dannenberg J.H., Joseph N., Gao J., Nieland T.J., Zhou Y., Wang X., Mazitschek R., Bradner J.E., DePinho R.A., Jaenisch R., Tsai L.H. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009, 459:55-60.
17. Haddad J.J. N-Methyl-d-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention?. Prog Neurobiol 2005, 77:252-282.
18. Hattox A.M., Nelson S.B. Layer V neurons in mouse cortex projecting to different targets have distinct physiological properties. J Neurophysiol 2007, 98:3330-3340. Epub 2007 Sep 26.
19. Hisaoka K., Takebayashi M., Tsuchioka M., Maeda N., Nakata Y., Yamawaki S. Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells. J Pharmacol Exp Ther 2007, 321:148-157.
20. Hu P., Oomen C., van Dam A.M., Wester J., Zhou J.N., Joëls M., Lucassen P.J. A single-day treatment with mifepristone is sufficient to normalize chronic glucocorticoid induced suppression of hippocampal cell proliferation. PLoS One 2012, 7:e46224. Epub 2012 Sep 25. 10.1371/journal.pone.0046224.
21. Hynd M.R., Scott H.L., Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 2004, 45:583-595.
22. Kiss J.P., Szasz B.K., Fodor L., Mike A., Lenkey N., Kurko D., Nagy J., Vizi E.S. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine. Neurochem Int 2012, 60:170-176.
23. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 2000, 351(Pt. 2):289-305.
24. Kugaya A., Sanacora G. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 2005, 10:808-819.
25. Kuipers S.D., Trentani A., Den Boer J.A., Ter Horst G.J. Molecular correlates of impaired prefrontal plasticity in response to chronic stress. J Neurochem 2003, 85:1312-1323.
26. Lefloch R., Pouyssegur J., Lenormand P. Total ERK1/2 activity regulates cell proliferation. Cell Cycle 2009, 8:705-711.
27. Mattson M.P. Calcium and neurodegeneration. Aging Cell 2007, 6:337-350.
28. Müller M.B., Lucassen P.J., Yassouridis A., Hoogendijk W.J., Holsboer F., Swaab D.F. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 2001, 14:1603-1612.
29. Navarrete M., Araque A. Endocannabinoids mediate neuron-astrocyte communication. Neuron 2008, 57:883-893.
30. Parent M.A., Wang L., Su J., Netoff T., Yuan L.L. Identification of the hippocampal input to medial prefrontal cortex in vitro. Cereb Cortex 2010, 20:393-403.
31. Parpura V., Haydon P.G. Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc Natl Acad Sci U S A 2000, 97:8629-8634.
32. Patterson M., Yasuda R. Signalling pathways underlying structural plasticity of dendritic spines. Br J Pharmacol 2011, 163:1626-1638.
33. Paul S., Nairn A.C., Wang P., Lombroso P.J. NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat Neurosci 2003, 6:34-42.
34. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotoxic Coordinates 2001, Academic Press, San Diego. Second ed.
35. Puschmann T.B., Dixon K.J., Turnley A.M. Species differences in reactivity of mouse and rat astrocytes in vitro. Neurosignals 2010, 18:152-163.
36. Qi X., Lin W., Li J., Li H., Wang W., Wang D., Sun M. Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiol Dis 2008, 31:278-285.
37. Qi X., Lin W., Wang D., Pan Y., Wang W., Sun M. A role for the extracellular signal-regulated kinase signal pathway in depressive-like behavior. Behav Brain Res 2009, 199:203-209.
38. Rajkowska G., Miguel-Hidalgo J.J. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 2007, 6:219-233.
39. Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
40. Schmidt E.F., Warner-Schmidt J.L., Otopalik B.G., Pickett S.B., Greengard P., Heintz N. Identification of the cortical neurons that mediate antidepressant responses. Cell 2012, 149:1152-1163.
41. Tanis K.Q., Duman R.S. Intracellular signaling pathways pave roads to recovery for mood disorders. Ann Med 2007, 39:531-544.
42. Trentani A., Kuipers S.D., Ter Horst G.J., Den Boer J.A. Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: implications for stress-related cortical pathology?. Eur J Neurosci 2002, 15:1681-1691.
43. Valjent E., Pages C., Herve D., Girault J.A., Caboche J. Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 2004, 19:1826-1836.
44. Vantaggiato C., Formentini I., Bondanza A., Bonini C., Naldini L., Brambilla R. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 2006, 5:14.
45. Voisin L., Saba-El-Leil M.K., Julien C., Fremin C., Meloche S. Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation. Mol Cell Biol 2010, 30:2918-2932.
46. Yang S.H., Sharrocks A.D. SUMO promotes HDAC-mediated transcriptional repression. Mol Cell 2004, 13:611-617.
47. Yang S.H., Sharrocks A.D. PIASxalpha differentially regulates the amplitudes of transcriptional responses following activation of the ERK and p38 MAPK pathways. Mol Cell 2006, 22:477-487.